Oxford MEStar
Oxford MEStar is a company focused on translational and regenerative medicine, dedicated to developing innovative technologies and providing bioengineering solutions. It specializes in creating products and services for the translational and regenerative medicine industry, particularly in the areas of stem cell processing, engineered tissue manufacturing, and cellular bioproducts. The company possesses significant technical expertise in bioprocessing, bioengineering, and bio-manufacturing, allowing it to offer advanced solutions such as 3D bioprinting and in-vitro diagnostic development. Oxford MEStar also facilitates technology transfer between the UK and China, enhancing collaboration in the field of regenerative medicine.
MODE Diagnostics
Acquisition in 2016
Mode Diagnostics focuses on creating innovative diagnostic products for bowel cancer screening by utilizing the electrochemical properties of biomarkers. The company has developed a range of technologies that include assay development techniques, biosensing capabilities, microfabrication, electronics, and wireless communications. Its proprietary platform, known as "measure," is designed to be flexible, low-cost, and hygienic, making it suitable for both physician offices and consumer self-testing. Mode Diagnostics aims to provide user-friendly and medically informative health screening solutions, with its flagship product, measure BOWEL HEALTH, offering significant advancements over traditional fecal occult blood testing methods. This product enhances the efficiency of bowel cancer screening for healthcare providers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.